Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:02 PM
Ignite Modification Date:
2025-12-24 @ 4:02 PM
NCT ID:
NCT06694766
Eligibility Criteria:
Inclusion Criteria:
Common :
* Person over 18 years of age at the time of the first yellow fever vaccination
* Female gender
* Oral consent obtained after subject has been informed
* Subject covered by Social Security with the exception of Aide Médicale d'Etat
Specific to both groups :
* For women vaccinated during pregnancy (case): Primary yellow fever vaccination during pregnancy
* For women vaccinated outside pregnancy (control): Primary yellow fever vaccination outside pregnancy
Exclusion Criteria:
Criteria common to both sections (tolerance and immunogenicity):
* Subject having received a second yellow fever vaccination
* Persons unable to give informed consent for participation
* Women born in areas where yellow fever is endemic
* Female adults under legal protection (guardianship or trusteeship)
Specific criteria for participants in the immunogenicity section:
* Medical condition imcompatible with 18.5 mL blood
* Women who have not given written consent to participate in the study. immunogenicity
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT06694766
Study Brief:
Protocol Section:
NCT06694766